Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen
type: MedicalStudy
description: A Multinational, Randomized, Double-blind Study, Comparing the Efficacy of Aflibercept Once Every 2 Weeks Versus Placebo in Patients With Metastatic Colorectal Cancer (MCRC) Treated With Irinotecan / 5-FU Combination (FOLFIRI) After Failure of an Oxaliplatin Based Regimen
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE3
start date: 2007-11
end date: 2012-06
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00561470
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Sanofi
study subject: Colorectal Neoplasms
study subject: Neoplasm Metastasis
keywords: PHASE3
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Colorectal Neoplasms
keywords: Neoplasm Metastasis

AI Analytics
type: Organization